NWBO

Northwest Biotherapeutics Inc

A biotechnology company building personalized cancer vaccines called DCVax that use a patient's own immune cells to target their tumor, rather than a one-size-fits-all drug. Its lead product, DCVax-L, is being developed for glioblastoma, an aggressive brain cancer. The company was founded in 1996 by Dr. Alton Boynton, a scientist from Seattle's Pacific Northwest, the region that inspired its name; he had earlier led research at the Pacific Northwest Research Foundation that later gave rise to the Fred Hutchinson Cancer Center.

CUSIP: 66737P600HealthcareUS1 holder

Ownership Activity Financials Filings

NWBO

NWBO

Entry into a Material Definitive Agreement

Regulation FD Disclosure

Completion of Acquisition or Disposition of Assets

Other Events

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Entry into a Material Definitive Agreement

Entry into a Material Definitive Agreement

Entry into a Material Definitive Agreement